Cambridge Healthtech Institute’s 14th Annual

Engineering Bispecific Antibodies

Designing New Antibody Therapies

16 November 2023

Innovative platforms and engineering approaches have created the next generation of bispecific antibodies with novel functionalities and features. However, the challenge is to identify attributes early in the process to make necessary improvements to constructs and avoid failures in the clinic late in the development process. Join this year’s leading experts as we explore one of the most exciting areas in biologics and discover what the newest platforms and engineering approaches are that promise an increasingly diverse array of new constructs and strategies that can achieve unprecedented efficacy.   

Coverage will include, but is not limited to:

  • Engineering bispecifics for applications in oncology and beyond
  • Determining developability parameters
  • Advancing conditionally-active bispecifics
  • Targeting solid tumors
  • Creating bispecific co-stimulatory combinations
  • Developing novel oncolytic virus bispecifics

The deadline for priority consideration is 31 March 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

For more details on the conference, please contact:

Christina Lingham
Executive Director, Conferences and Fellow
Cambridge Healthtech Institute
Phone: (+1) 781-972-5464

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340